Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Clinical Nephrology

• Publication date

  1984-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 6441659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta 2-microglobulin in chronic lymphocytic leukaemia.

  2009cited by this paper
• Measurement of serum amyloid A protein concentrations as test of renal allograft rejection in patients with initially non-functioning grafts.

  1984cited by this paper
• SERUM AMYLOID A PROTEIN: A SENSITIVE INDICATOR OF RENAL ALLOGRAFT REJECTION IN HUMANS

  1983cited by this paper
• Beta 2 microglobulin and the diagnosis of cardiac transplant rejection.

  1983cited by this paper
• BETA‐2‐MICROGLOBULIN: QUANTITATION BY ROCKET IMMUNOELECTROPHORESIS AND EVALUATION OF SERUM LEVELS IN RENAL TRANSPLANT PATIENTS

  1983cited by this paper
• Serum amyloid A levels in human renal allograft rejection.

  1983cited by this paper
• Amyloid A fibril degrading activity in serum in liver disease--relation to serum acute phase and other protein levels.

  1983cited by this paper
• The acute phase response and its relation to amyloid A degrading activity in serum of patients with rheumatoid arthritis undergoing arthroplasty

  1983cited by this paper
• Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis.

  1983cited by this paper
• Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance.

  1983cited by this paper
• Serum beta 2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus.

  1982cited by this paper
• THE BIOLOGY OF SAA: IDENTIFICATION OF THE INDUCER, IN VITRO SYNTHESIS, AND HETEROGENEITY DEMONSTRATED WITH MONOCLONAL ANTIBODIES *

  1982cited by this paper
• Glucocorticosteroids in Renal Transplantation

  1982cited by this paper
• Induction of hepatic synthesis of serum amyloid A protein and actin.

  1981cited by this paper
• Prediction of onset and termination of renal allograft rejection by serum levels of C-reactive protein.

  1981cited by this paper
• The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen.

  1981cited by this paper
• C-reactive protein fifty years on.

  1981cited by this paper
• Beta 2-microglobulin monitoring after renal transplantation.

  1981cited by this paper
• Monitoring of Human Renal Allograft Rejection with Fine‐needle Aspiration Cytology

  1981cited by this paper
• Cyclosporin-A in clinical organ grafting.

  1981cited by this paper
• Monokine-induced synthesis of serum amyloid A protein by hepatocytes

  1980cited by this paper
• beta2-microglobulin in monitoring renal transplant function.

  1979cited by this paper
• Effect of purified protein SAA on immune response in vitro: mechanisms of suppression.

  1979cited by this paper
• beta2-Microglobulin production by highly purified human T and B lymphocytes in cell culture stimulated with various mitogens.

  1979cited by this paper
• Detection of a mediator derived from endotoxin-stimulated macrohpages that induces the acute phase serum amyloid A response in mice

  1979cited by this paper
• Induction of the acute-phase serum protein SAA requires both RNA and protein synthesis.

  1978cited by this paper
• Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

  1978cited by this paper
• Plasma and urinary levels of beta2 microglobulin in rheumatoid arthritis.

  1978cited by this paper
• beta 2 Microglobulin, a tumour marker of lymphoproliferative disorders.

  1978cited by this paper
• Amyloid-related serum component (SAA)--studies in acute infections, medullary thyroid carcinoma, and postsurgery.

  1976cited by this paper
• Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome.

  1975cited by this paper
• Aggregation of HL-A Antigens at the Lymphocyte Surface Induced by Antiserum to β2-Microglobulin

  1973cited by this paper
• THE SMALL SUBUNIT OF HL-A ANTIGENS IS β2-MICROGLOBULIN

  1973cited by this paper
• Fine-needle aspiration biopsy in the diagnosis of human renal allograft rejection.

  1973cited by this paper
• 2 -Microglobulin. A marker of renal homograft survival.

  1973cited by this paper
• Serum 2 -microglobulin in renal disease.

  1973cited by this paper
• Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

  1968cited by this paper

• Serum Amyloid A as an Early Marker of Infectious Complications after Laparoscopic Surgery for Colorectal Cancer

  2018cites this paper
• Equine Septic Arthritis and Serum Amyloid A

  2016cites this paper
• Acute phase proteins and liver allograft rejection.

  2008cites this paper
• Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers.

  2007cites this paper
• Serum Concentrations of Adiponectin and Serum Amyloid A in Patients with End-Stage Renal Disease and Following Successful Kidney Transplantation

  2006cites this paper
• Serum amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio.

  2005cites this paper
• Cystatin-C and creatinine as indices of glomerular filtration rate in the immediate follow-up of renal transplant patients

  2005cites this paper
• Excretion of urinary proteins as predictors of early posttransplantation complications and late renal allograft failure

  2005influential citation
• Antibodies to amyloid A protein in rheumatic diseases

  2004cites this paper
• Role of Neopterin in Immune Monitoring in Transplant Medicine

  2002cites this paper
• Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis

  2001cites this paper
• SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 (sICAM-1) AFTER KIDNEY TRANSPLANTATION: THE ORIGIN AND ROLE OF URINARY sICAM-1?1

  2001cites this paper
• Examination of serum amyloid A protein in kidney transplant patients.

  2000cites this paper
• C-reactive Protein and Serum Amyloid A protein in Neonatal Infections

  2000cites this paper
• Changes of urinary alpha1-microglobulin in the assessment of prognosis in renal transplant recipients.

  2000cites this paper
• Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness

  1999cites this paper
• Acute Phase Response in Dairy Cows with Experimentally Induced Escherichia coli Mastitis

  1999cites this paper
• Examination of serum amyloid A protein in kidney transplant patients--comparison of serum amyloid A and C-reactive protein for monitoring the occurrence of renal-allograft-related complications.

  1998cites this paper
• Noninvasive monitoring using serum amyloid A and serum neopterin in cardiac transplantation.

  1998cites this paper
• Does increased urinary interleukin-1 receptor antagonist/interleukin-1beta ratio indicate good prognosis in renal transplant recipients?

  1998cites this paper
• The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study.

  1998cites this paper
• Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejection.

  1997cites this paper
• [Production of inflammatory markers by HepG 2 cells stimulated with monocyte conditioned media: the effects of corticosteroid and other immunosuppressants].

  1997cites this paper
• Pancreas-specific protein (PASP), serum amyloid A (SAA), and neopterin (NEOP) in the diagnosis of rejection after simultaneous pancreas and kidney transplantation

  1997cites this paper
• Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.

  1997cites this paper
• The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejection

  1996cites this paper
• Increased serum neutral endopeptidase activity in acute renal allograft rejection.

  1996cites this paper
• Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice

  1996cites this paper
• Serum Amyloid A Protein in the Prediction of Postburn Complications and Fatal Outcome in Patients with Severe Burns

  1996cites this paper
• Serum C-reactive protein. A useful and economical marker of immune activation in renal transplantation.

  1996cites this paper
• Serum amyloid A protein monitoring for early prediction of kidney allograft rejection.

  1995cites this paper
• Serum Amyloid a Protein in Patients with Acute Myocardial Infarction

  1995cites this paper
• The diagnostic capacity of serum amyloid A protein for early recognition of kidney allograft rejection.

  1995cites this paper
• Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosis

  1994cites this paper
• Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid.

  1994cites this paper
• A Rapid Enzyme-Linked Immunosorbent Assay for Serum Amyloid a Using Sequence-Specific Antibodies

  1993cites this paper
• De novo amyloidosis in a renal allograft: a case report and review of the literature.

  1993cites this paper
• Pharmacodynamic Monitoring of Cyclosporin

  1992cites this paper
• Prospective analysis of 10 different parameters of acute renal allograft rejection.

  1992cites this paper
• [A comparative study of the plasma amyloid A level as well as of 9 other parameters in allograft rejection].

  1992cites this paper
• Production of serum amyloid A and C‐reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone

  1992cites this paper
• Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.

  1992cites this paper
• Diagnosis of viral infections under therapy with OKT3 and antithymocyte globulin.

  1992cites this paper
• Comparison of serum amyloid A and C‐reactive protein as indicators of lung inflammation in corticosteroid treated and non‐corticosteroid treated cystic fibrosis patients

  1992cites this paper
• Acute-phase proteins during hemodialysis: correlations with serum interleukin-1 beta levels and different dialysis membranes.

  1991cites this paper
• Serum Amyloid a and C-Reactive Protein in the First 4 Weeks after Liver Transplantation

  1991cites this paper
• Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator.

  1991cites this paper
• Diagnostische Strategien bei Abstoßungsreaktionen nach Nierentransplantation

  1991cites this paper
• A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein.

  1991cites this paper
• Evaluation of Acute-Phase Proteins for Clinical Monitoring of Urinary Tract Infections and Postoperatively

  1991cites this paper
• Acute phase response in cerebral infarction.

  1989cites this paper
• Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases.

  1989cites this paper
• Serum amyloid A protein concentration measured by radial immunodiffusion in Abyssinian and non-Abyssinian cats.

  1989cites this paper
• Combined measurements of urinary neopterin, beta 2-microglobulin and serum gamma-interferon for early detection of renal graft rejection following change from cyclosporin A to immunosuppressive combination therapy.

  1989cites this paper
• Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction.

  1988cites this paper
• Renal transplantation for dialysis arthropathy.

  1988cites this paper
• SERUM C‐REACTIVE PROTEIN CONCENTRATIONS IN CYCLOSPORINE‐TREATED RENAL ALLOGRAFT RECIPIENTS1

  1988cites this paper
• Class specific rheumatoid factors and their complement binding property in the sera of patients suffering from recent-onset rheumatoid arthritis.

  1988cites this paper
• Mechanism ofanaemia inrheumatoid arthritis: demonstration ofraised interleukin 1 concentrations inanaemic patients andofinterleukin 1mediated suppression ofnormalerythropoiesis and proliferation ofhumanerythroleukaemia (HEL)cells invitro

  1988cites this paper
• Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

  1988cites this paper
• The clinical significance of serum C-reactive protein after renal transplantation.

  1988cites this paper
• Monitoring of high-density lipoprotein-associated amyloid A protein after liver transplantation.

  1987cites this paper
• Computer Aided Decision Support for Post-Transplant Renal Allograft Rejection

  1987cites this paper
• INCREASED FACTOR VIII AS AN INDEX OF VASCULAR INJURY IN CYCLOSPORINE NEPHROTOXICITY

  1986cites this paper
• The significance of beta-2 microglobulin in clinical medicine.

  1985cites this paper
• Posttransplantation monitoring of high-density lipoprotein-associated serum amyloid A protein: a new diagnostic aid in the detection of renal allograft rejection.

  1985cites this paper